As the Houston Business Journal reported, the first CARE Token transaction took place on February 5. Pinto Walia used 450 CARE ($4,500 USD) to get stem cell therapy from Dr. Naz Keshwani, who runs a medical practice in Houston, Texas. Dr. Keshwani will accept CARE in addition to other forms of payment and offer a steep discount as a result.
“It’s exciting,” Keshwani told the Houston Business Journal. “I feel like I’m on the forefront.”
CARE Tokens are pegged at $10 USD for the duration of the token sale. When investments reach 20 million USD, the price will rise to $20 USD before going on crypto exchanges later in the year.
“We are carefully managing the process of joining exchanges to avoid volatility,” said CareX CEO Mike Bishop.
“Patients can now use CARE tokens with any provider that will accept them,” explains Bishop. “We will now be focused on growing that network.”
“Having easy access to health records give patients the freedom to choose their provider,” said Bishop. “When providers start competing for patients, everybody wins.”
By accepting tokens, providers will get free access to the CareX suite of products, including analytics software that helps manage the administrative side of their business, saving lots of time and money. They also get access to the global network of patients interested in getting services.
“The more patients I can see, the cheaper my costs per patient could be,” said Dr. Ilyas Benchalaa, a CareX associated physician. “That’s a virtuous cycle which could really benefit everyone I work with.”
This is a paid press release. Blockchain Healthcare Review does not endorse and is not responsible for or liable for any content, accuracy, quality, advertising, products or other materials on this page. Readers should do their own research before taking any actions related to the company. Blockchain Healthcare Review is not responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in the press release.